These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10229107)

  • 1. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12.
    Kodama T; Takeda K; Shimozato O; Hayakawa Y; Atsuta M; Kobayashi K; Ito M; Yagita H; Okumura K
    Eur J Immunol; 1999 Apr; 29(4):1390-6. PubMed ID: 10229107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
    Smyth MJ; Crowe NY; Pellicci DG; Kyparissoudis K; Kelly JM; Takeda K; Yagita H; Godfrey DI
    Blood; 2002 Feb; 99(4):1259-66. PubMed ID: 11830474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
    Dao T; Mehal WZ; Crispe IN
    J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity.
    Matsumoto G; Omi Y; Lee U; Nishimura T; Shindo J; Penninger JM
    Eur J Immunol; 2000 Dec; 30(12):3723-31. PubMed ID: 11169416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.
    Hyodo Y; Matsui K; Hayashi N; Tsutsui H; Kashiwamura S; Yamauchi H; Hiroishi K; Takeda K; Tagawa Y; Iwakura Y; Kayagaki N; Kurimoto M; Okamura H; Hada T; Yagita H; Akira S; Nakanishi K; Higashino K
    J Immunol; 1999 Feb; 162(3):1662-8. PubMed ID: 9973427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent.
    Smyth MJ; Taniguchi M; Street SE
    J Immunol; 2000 Sep; 165(5):2665-70. PubMed ID: 10946296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12.
    Takeda K; Hayakawa Y; Atsuta M; Hong S; Van Kaer L; Kobayashi K; Ito M; Yagita H; Okumura K
    Int Immunol; 2000 Jun; 12(6):909-14. PubMed ID: 10837418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice.
    Argentati K; Bartozzi B; Bernardini G; Di Stasio G; Provinciali M
    Eur Cytokine Netw; 2000 Mar; 11(1):59-66. PubMed ID: 10705300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current advances and expectations in tumor immunology].
    Takeda K; Okumura K
    Hum Cell; 2001 Sep; 14(3):159-63. PubMed ID: 11774735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S; Komita H; Sagawa Y; Ohno T; Toda G
    Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perforin is a major contributor to NK cell control of tumor metastasis.
    Smyth MJ; Thia KY; Cretney E; Kelly JM; Snook MB; Forbes CA; Scalzo AA
    J Immunol; 1999 Jun; 162(11):6658-62. PubMed ID: 10352283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
    Grundy MA; Zhang T; Sentman CL
    Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
    Bose A; Baral R
    Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of natural killer cells with interleukin 2 (IL-2) and IL-12 increases perforin binding and subsequent lysis of tumour cells.
    Lehmann C; Zeis M; Uharek L
    Br J Haematol; 2001 Sep; 114(3):660-5. PubMed ID: 11552995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
    Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.